Duplex sequencing (Ds) is a next-generation sequencing methodology capable of detecting a single mutation among >1 × 10 7 wild-type nucleotides, thereby enabling the study of heterogeneous populations and very-low-frequency genetic alterations. Ds can be applied to any double-stranded Dna sample, but it is ideal for small genomic regions of <1 Mb in size. the method relies on the ligation of sequencing adapters harboring random yet complementary double-stranded nucleotide sequences to the sample Dna of interest. Individually labeled strands are then pcr-amplified, creating sequence 'families' that share a common tag sequence derived from the two original complementary strands. Mutations are scored only if the variant is present in the pcr families arising from both of the two Dna strands. Here we provide a detailed protocol for efficient Ds adapter synthesis, library preparation and target enrichment, as well as an overview of the data analysis workflow. the protocol typically takes 1-3 d. retained only if the two strands match perfectly at that position, yielding a 'duplex consensus sequence' (DCS; Fig. 1c ). Mutations introduced during PCR by DNA polymerase misincorporations or arising from DNA damage will appear in only one of the two DNA strands and thus are not counted as real mutations.
IntroDuctIon
Next-generation DNA sequencing (NGS) defines the modern genomic era. This powerful technology has revolutionized traditional genetics and has made feasible the emerging field of personalized medicine. It is now routine to sequence billions of nucleotides and to identify inherited clonal mutations. However, all NGS approaches have a relatively high error rate: on the order of one erroneous base call per 100-1,000 sequenced nucleotides ( Table 1 ; ref. 1) . Although this error rate is acceptable for studying inherited mutations, it greatly limits the analysis of subclonal mutations, which are defined as mutations that are present in only a fraction of cells within a population.
There is growing need for technologies capable of resolving subclonal mutations. For example, genetic heterogeneity has long been proposed to be an intrinsic driver of cancer initiation and progression 2 . Recent tumor genome sequencing studies suggest that human cancers exhibit extreme levels of genetic heterogeneity [3] [4] [5] [6] . Subclonal mutations are probably a major factor in cancer relapse and in rapid emergence of chemotherapy resistance [7] [8] [9] . However, the study of cancer subclones requires the confident detection of mutations that are present in <1% of cells-a level of resolution that cannot be obtained by conventional sequencing approaches. Similarly, the genetic diversity found within microbial populations underlies their ability to adapt to changing environments, including development of drug resistance [10] [11] [12] [13] , but this genetic diversity is difficult to directly assess owing to the high background error rate of conventional NGS sequencing. Other fields with a similar need for robust low-frequency mutation detection include forensics 14 , paleogenomics 15, 16 , evolution 17 and toxicology 18 , as high-accuracy sequencing would allow one to assess the potential mutagenicity of new chemical compounds without the need for a genetic selection system to identify mutant genes.
The concept of DS
To overcome the high error rate of next-generation sequencing and thereby facilitate the study of subclonal and random mutations, we recently developed a highly sensitive sequencing methodology termed Duplex Sequencing (DS). DS yields unprecedented accuracy in sequencing of double-stranded DNA, with a >10,000-fold improvement compared with conventional NGS, and it has the unique ability to detect a single mutation among >10 7 sequenced bases 19 . DS takes advantage of the inherent complementarity of double-stranded DNA by using degenerate molecular tags [20] [21] [22] [23] [24] [25] [26] to label each fragmented DNA molecule with its own unique DNA sequence. By tagging duplex DNA with adapters containing random yet complementary double-stranded nucleotide sequences, it becomes feasible to trace every sequence read back to one of the two strands of the original double-stranded DNA molecule (Fig. 1a) . After adapter ligation, the individually labeled strands are PCR-amplified to create sequence families that share the same tag sequences derived from each of the two single parental strands (Fig. 1b) . After sequencing, members of each tag family are grouped and a consensus sequence is established for each of the two strands to form 'single-strand consensus sequences' (SSCSs; Fig. 1c ). The two complementary consensus sequences derived from the two strands of an individual DNA duplex are then compared with each other, and the base identity at each position is
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Advantages of DS
The primary advantage of DS over other approaches is its superior accuracy. In our original publication on DS 19 , we demonstrated the direct measurement of the mutation frequency for the M13 bacteriophage as 2.5 × 10 −6 mutations per base pair. We have subsequently measured mutation frequencies as low as 5 × 10 −8 in human nuclear DNA (E.J.F. and L.A.L., unpublished results). In addition, we recently applied DS to measuring the mutation frequency of human mtDNA in brain tissue from young and old individuals 33 . We showed that the frequency of mtDNA point mutations is 10-100-fold lower than that previously reported, and the frequency increases approximately fivefold over an 80-year lifespan. Surprisingly, we observed no significant age-associated increase in the mutations most commonly associated with oxidative damage to mtDNA. This finding is inconsistent with free-radical theories of aging and suggests that previous studies indicating that reactive oxygen species induced mutations increase with age may be the result of PCR artifacts.
Similarly to our results with mtDNA, we have found that DS can help mitigate artifactual mutations derived from chemically damaged DNA. Numerous studies using NGS to sequence DNA from formalin-fixed tissues have reported a high number of false mutations [34] [35] [36] . Because complementary artifacts from damage events are unlikely to occur at the same corresponding position on paired DNA strands, the use of sequencing information from both strands to correct these errors makes DS extremely resistant to damage-induced misincorporations. By using DS, we have sequenced paired formalin-fixed and unfixed tissue samples, and we found only a twofold change in the mutation frequency, indicating that DS is useful for removing mutational artifacts even in extremely damaged and degraded DNA (M.J.P., E.J.F. and L.A.L., unpublished results).
Limitations of DS
DS is a uniquely sensitive method that is capable of detecting and quantifying mutations that occur at extremely low frequencies; however, this ability comes at a cost. Owing to the method's reliance on sequencing multiple PCR duplicates of both DNA strands, DS requires much larger sequencing capacity than conventional NGS to produce a given depth of sequencing. At present, the use of current NGS technology with DS to sequence large genomes or genome targets >1-2 Mbp in size to a high depth of coverage is prohibitively expensive; however, as the cost of sequencing continues to fall, we anticipate that this will become increasingly practical.
Overview of the procedure
Sequencing library construction for DS is similar to the standard Illumina library preparation protocol. The protocol follows the basic standard steps of DNA shearing by sonication, size selection, end repair, 3′ dA-tailing, adapter ligation, PCR amplification and, optionally, targeted DNA capture. We have made several important updates and optimizations to the protocol since its initial publication, which have substantially increased its reliability and reproducibility. Specifically, we have re-designed the sequencing adapters to allow for more efficient dA-tailing of the sample DNA. As part of this new design, the adapters require a different synthesis method that we have included in Boxes 1 and 2. An additional change in the protocol involves the amount of DNA used during the PCR step. In the original publication, we specified that ~40 attomoles of DNA was optimal. However, we have since determined that the PCR input amount depends on a number of factors, including the number of reads devoted to a sample, the
Box 1 | Synthesis of DS adapters • tIMInG 2 d
The adapter synthesis protocol generates a sufficient amount of adapters for several hundred samples. 6. Divide the solution into aliquots in 1.5-ml tubes, 275 µl per tube (~2 tubes total), and add 675 µl (i.e., 2.5 volumes) of room-temperature 100% ethanol to each tube; mix the tubes by inversion. ? troublesHootInG 7. Centrifuge the mixture for 30 min at 4 °C at >10,000g. 8. Remove the supernatant, add 1 ml of 75% (vol/vol) ethanol to each tube and mix by inversion. Immediately centrifuge the tubes for 30 min at 4 °C at >10,000g. 9. Remove the supernatant. Dry the tube for 10 min inverted on a paper towel, and then for 5 min upright.  crItIcal step Dry the DNA pellet for the exact times specified. Overdrying the DNA could lead to strand melting. 10. Resuspend the pellet in each tube with 100 µl TE low . After resuspension, pool all the tubes together for a final volume of 200 µl. Remove and save 1 µl for quality control; label as 'final adapters' . 11. Divide the adapters into 50-µl aliquots, and place them at −80 °C for long-term storage. The final concentration will be ~50 µM. 12. (Optional) Radiolabel the sample from each step and run it on an 8 M urea, 14% (wt/vol) acrylamide gel (Fig. 2a) . Although this step is optional, it is strongly recommended. See box 2 for a detailed protocol. ! cautIon γ-32 P-ATP is radioactive. Take appropriate steps to avoid exposure to radioactive compounds. ? troublesHootInG use of targeted DNA capture, genome and target size, and gene and target copy number. We formally outline the relationship between these parameters and provide the optimal DNA input amounts to maximize the final amount of data. Finally, we have included the option to use targeted DNA capture, which greatly expands the utility of DS beyond small, highly pure genomes, such as mtDNA and other small plasmids that were presented in our original publication. In addition to the updated protocol, we also include a comprehensive computational pipeline that we use to process and analyze our data (Fig. 2) . The computational workflow for DS uses a number of standard software packages to process the sequencing data; these include the Burrows-Wheeler Aligner (BWA) 37 , SAMtools 38 , Picard and the Genome Analysis Toolkit (GATK) 39, 40 , as well as several custom Python scripts. The computational workflow is broken down into three major steps: (i) Tag parsing and initial alignment; (ii) SSCS assembly; and (iii) DCS assembly. The latest version of the DS software package can be downloaded from https://github.com/loeblab/Duplex-Sequencing.
Each read obtained from a DS run consists of a 12-nt tag sequence, followed by an invariant 5-bp sequence corresponding to the ligation site. First, the invariant 5-bp sequence is computationally removed from each read, and the 12-nt tag present on each of the two paired-end reads is combined to a single 24-nt tag that is stored in the read header. Sequences with ambiguous nucleotides or homopolymers greater than nine bases within the tag are discarded. These steps are all performed by the custom python script called 'tag_to_header.py' (Supplementary Fig. 1) . The reads are then aligned to the reference genome using BWA 37 . After alignment, reads sharing the same tag sequence and genomic coordinates are identified and grouped to form 'tag families' with a python script called 'ConsensusMaker.py'. By default, the script requires three members to result in a tag family. The family members are then compared at each sequence position, and the identity of a position is kept only when at least 70% of the members have the same sequence at that position. Positions that cannot form a consensus are replaced by an 'N' and are considered undefined. The resulting data are referred to as SSCSs (Supplementary Fig. 2) . We have experimented with requiring more than three members per family or >70% sequence agreement, but we have found that this reduces data yield without any appreciable change in the method's accuracy (Supplementary Fig. 3) .
Next, the two related SSCS reads corresponding to the two initial DNA strands are grouped together and compared by a script called 'DuplexMaker.py'. The 24-nt tag associated with each sequence read consists of two 12-nt sequences, and the tags corresponding to a pair of SSCS reads can be grouped by virtue of being transposed relative to one another. Specifically, if the two 12-nt sub-tag sequences are designated α and β, then a sequence with a tag αβ in read 1 is compared with the sequence having the tag βα in read 2. The paired strand SSCS reads are then compared at each position, with only matching bases being kept to produce a DCS. Non-matching bases are considered undefined, and they are replaced by 'N' . Reads containing a high proportion of Ns (>30%) are filtered out during this step (Supplementary Fig. 4) . The processed DCS data are then re-aligned to the reference genome.
Experimental design
In the following sections, we will highlight important considerations that should be taken into account for each stage in the protocol, as well as provide details about the changes and improvements we have made since the initial publication 19 .
Box 2 | Optional quality control steps for adapter synthesis using radiolabeled adapters and PAGE • tIMInG 1 d
The following steps provide a method by which to evaluate the synthesis of the adapters. We have found that the use of radiolabeling with polyacrylamide electrophoresis provides the most consistent and sensitive way to evaluate the success of the adapter synthesis steps. Agarose electrophoresis could also be used; however, the fluorescent dyes used require double-stranded DNA. Therefore, the evaluation of the extension step (step 3) will be limited. Technical solutions, such as the Agilent TapeStation 2200 or Bioanalyzer 2100, do not have enough resolution to detect the 9-bp size change that occurs during enzymatic restriction (step 4) and should be avoided. Sample requirements. The amount of fragmented DNA actually used in the PCR amplification step is typically in the low-attomole range, so the theoretical amount of starting DNA needed for DS is extremely low. However, when feasible, it is most convenient to start with excess amounts of DNA to allow for easy quantification of the DNA throughout the initial sample preparation steps and to account for expected sample loss at the enzymatic and purification steps. Typically, 1-3 µg of DNA is required for targeted DNA capture and 100-300 ng of DNA for smaller genomes, such as purified plasmid or mtDNA, that do not require targeted capture. When performing DNA isolation, it is imperative to avoid any manipulations that could result in melting of the two DNA strands, such as heating above 80 °C, the use of chaotropic agents such as urea or overdrying the DNA during ethanol precipitations.
DNA fragmentation. We physically shear the DNA by sonication using a Covaris acoustic ultrasonicator. The shearing time is varied depending on the size of the genome, with shorter times for small genomes (such as mtDNA or viral DNA) and longer times for nuclear DNA. Specific shearing parameters are given in Equipment Setup below. Other methods such as nebulization or enzymatic digestion should both be compatible with DS, but would probably require optimization. 'Tagmentation' methods, which involve simultaneous fragmentation of the sample DNA and ligation of sequencing adapters by a transposase (e.g., Illumina's Nextera DNA sample prep kit), are currently incompatible with DS because they make use of an invariant transposon sequence that is incompatible with molecular barcodes. Because the DNA strands are not marked with molecular barcodes, it is impossible to identify unique DNA molecules and perform the comparison between complementary strands.
Size selection. Many protocols for next-generation sequencing library preparation use PAGE, with excision and purification of the desired fragment range from the gel. However, gel-based size selection can result in melting of the two DNA strands, precluding its use with DS. In addition, the use of gels increases the introduction of DNA damage during UV transillumination. To mitigate these problems, we perform size selection with Ampure XP beads, which has the additional benefits of higher recovery and greater speed.
End repair and dA-tailing. Similar to the standard Illumina library construction protocol, the sheared DNA is subjected to end repair and 3′-end dA-tailing. Notably, in our initial description of DS 19 , we used A-tailed adapters and enzymatically added a 3′ dT overhang on the fragmented DNA sample. However, since then, we have determined enzymatic T-tailing to be considerably less efficient than A-tailing ( Supplementary Fig. 5 ), which results in a substantially reduced number of final reads. We have re-engineered the adapters to have a 3′ dT overhang (Fig. 1a , see 'Adapter synthesis' section and Boxes 1 and 2), which simultaneously increases the final data yield (Supplementary Table 1 ) and makes the protocol more consistent with conventional NGS library preparations.
Adapter synthesis. DS adapters are constructed by annealing two oligonucleotides, one of which contains a 12-nt singlestranded randomized tag sequence. A DNA polymerase is used to copy the degenerate tag sequence, thereby converting it to a double-stranded form (Fig. 3) . The extended product contains Adapter ligation. The DNA:adapter ratio is a crucial variable, as too few adapters lead to inefficient ligation, and the use of excess adapters can result in adapter dimers, which, owing to their small size, preferentially amplify during PCR. The presence of these adapter dimers interferes with DNA sequencing. To minimize the presence of adapter dimers, we determine the molar concentration of DNA molecules in the preligated DNA library on an Agilent TapeStation 2200 or Bioanalyzer 2100 and then use 20-fold molar excess of adapter relative to DNA. Unligated adapters and adapter dimers are then removed by purification with Ampure XP beads ( Supplementary Fig. 6 ).
Setting tag family size by PCR amplification. The sequencing library is PCR-amplified for the purpose of creating multiple copies of each strand of a double-stranded DNA molecule. The number of DNA fragments used in the PCR, along with the fraction of a sequencing lane dedicated to a particular sample, are the primary adjustable variables that dictate the number of sequencing reads that share the same tag sequence (i.e., tag family size), which strongly influences the final number of DCSs formed. If there are too few reads sharing the same tag sequence (i.e., small tag family size), a consensus sequence cannot be calculated; conversely, too many reads having the same tag sequence (i.e., large tag family size) wastes sequencing capacity without appreciably improving data yield. Because the number of reads varies between different tag families and occur in a distribution (Fig. 4) , we use 'peak family size' as our preferred metric to refer to tag family sizes generated under a given set of conditions. This distribution occurs during PCR amplification, and it is the result of different amplification efficiencies of the DNA molecules present in the library. By plotting the proportion of reads belonging to tag families of the same size (e.g., tag families can have the same number of reads as different tags) as a function of tag family size (the 'PE_reads. tagstats' file generated in
Step 60 of the PROCEDURE section provides these data), we typically observe a distribution of tag family sizes with a solitary peak at a tag family size of one, which is probably the result of sequencing errors in the tag region, and a broader distribution centered at the peak family size (see Fig. 4a as an example). We formally define peak family size as the tag family size >1 containing the highest proportion of reads. On the basis of the analysis of samples with different values for the peak family size, we have determined that a peak family size of six maximizes the efficiency of DS: that is, requiring the smallest number of raw reads to produce a single DCS (Fig. 5a) . Although We have found that a family size that is centered around approximately six members maximizes the final number of DCS reads. Samples that exhibit a small peak family size can be sequenced again and the raw sequencing data from the two sequencing runs can be combined and analyzed. Importantly, further sequencing of a sample with a large peak family size will not increase the final depth of coverage. The maximum efficiency of DCS formations occurs at a peak family size of six and corresponds to ~40 raw reads being required to form one DCS read.
(b) The total number of DCSs increases until a peak family size of ~16 is reached. A peak family size >16 does not result in an increase in the final number of DCSs.
a peak family size of six is optimal, it should be noted that data yield continues to increase, albeit at a decreasing overall efficiency, for peak family sizes ranging between six and 16 members (Fig. 5b) . As the peak family size approaches 16 reads per tag family, nearly all additional reads are redundant and consume sequencing capacity without yielding further DCS data. Therefore, when deciding on DNA input amounts for PCR, we aim for a peak family size ranging between six and 12 members. This range allows for some tolerance in peak family size because of pipetting or measurement error, while maximizing the final number of DCSs that we obtain. To achieve greater sequencing depth for a given target, or to achieve the same depth for a larger genome or genome target, more DCSs are needed. To increase the number of reads obtained in DS, it is necessary to proportionally increase both the input amounts of DNA for PCR and the dedicated lane fraction to maintain a peak family size of six ( Table 2) . Nonproportional changes to PCR input and lane fraction lead to suboptimal peak family sizes and substantial decreases in DS efficiency (Figs. 4b,c  and 5a ). The choice of lane fraction (i.e., the number of reads devoted to a particular sample) will be influenced by the size of the targeted region and the desired depth of coverage. In particular, for a given lane fraction, the final sequencing depth of a sample will decrease as the size of the genome target increases. The following formula can be used to estimate the number of reads to devote to a sample:
Where N is the number of paired-end reads devoted to a sample (i.e., lane fraction), D is the desired average depth of coverage, G is the genome or genome target size in base pairs and R is the postanalysis read length in bases (76 in our analysis). The value of 40 is an empirically determined pseudo-constant that approximately corresponds to the average number of unprocessed read-pairs needed to form a single DCS. This value roughly corresponds to the product of the optimal peak family size (i.e., six) and the number of SSCSs typically needed to form a single DCS (we typically obtain SSCS:DCS ratios between four and ten, with an average of around six). However, because not all raw reads are of high quality, several extra reads are typically present that fail to form a DCS, and this tends to raise the number of raw reads needed to form a single DCS to ~40. Notably, this formula provides a rough estimate of the depth that will be obtained provided that the peak family size and SSCS:DCS ratio are optimal. After determining the per-sample lane fraction, this value can be referred to in Table 2 to determine the amount of target DNA that should be used in the PCR to obtain the appropriate peak family size of six. For samples that do not make use of targeted capture, such as purified mtDNA or plasmid DNA, we have found that a PCR input of 40 amol of DNA produces an optimal peak family size of six when devoting eight million paired-end reads to a sample (i.e., ~5% sequencing capacity of a HiSeq2500 lane). For the 16.5-kb human mtDNA, this typically results in a depth of 500-1,000. Given the linear relationship between PCR input and lane fraction needed to keep the peak family size constant, 200 attomoles of input mtDNA for 25% of a HiSeq lane results in a depth of 2,500-5,000.
When performing targeted capture, a PCR input amount of 4 amol of target DNA is used for ~8 million paired-end reads (i.e., ~5% sequencing capacity of a HiSeq2500 lane). However, in contrast to a noncapture sample, this value refers specifically to the amount of target DNA being captured in the sample, which is generally much less than the amount of total DNA. The amount of total DNA used in the PCR is dependent on its relative copy number and the size of the genomic target, and it can be estimated by the following formula:
Where m is the desired amount of target DNA in attomoles of fragments ( Table 2) , G is the size of total genome in base pairs, T is the size of the target DNA in base pairs and N is the number of copies of the target per copy of the nontarget portion of the genome. For single-copy genes, N will have a value of 1 and can be ignored. However, in the case of multicopy targets such as mtDNA or ribosomal genes, N can be on the order of hundreds or thousands of copies per nontarget genome and can markedly influence the amount of input DNA. The value of N can be reasonably estimated by performing copy number analysis with quantitative PCR (qPCR) using primers that are specific to the target and nontarget DNA. Similar to the nontarget DNA inputs, the target DNA input amounts should also be proportionally increased with increasing lane fraction ( Table 2 ). The number of PCR cycles is an important variable. Additional cycles beyond the exponential phase can result in the appearance of nonspecific, higher-molecular-weight products (Fig. 6a,b) . To avoid this complication, we carefully monitor the number of PCR cycles. For samples requiring <10 fmol of input DNA, such as for mtDNA, we monitor the reaction by qPCR and remove the reactions one or two cycles before the SYBR Green signal plateaus, which typically occurs between cycles 15 and 20. Notably, the specific plateau point will be dependent on the amount of DNA used in the PCR and should be carefully monitored.
If a sample requires >10 fmol of DNA, such as when performing targeted capture of nuclear DNA, we have found that the SYBR Green signal can be unreliable. As a benchmark for determining the number of cycles that should be used during PCR, we have found that samples requiring ~600 fmol of total input DNA should be stopped between cycles six and eight. Importantly, for every twofold increase or decrease in the amount of DNA used in the PCR, the reactions should be stopped one cycle earlier or later, respectively. When first setting up DS for a new experimental system or genomic target, we recommend testing the number of cycles needed to maximize yield while avoiding higher-molecular-weight products by pausing the thermocycler every two cycles and carefully removing a small aliquot from the reaction. The aliquots can then be quantified on an Agilent TapeStation 2200 or Bioanalyzer 2100 to determine the optimal cycle number (Fig. 6a,b) .
Targeted DNA capture. Targeted capture of the sequences of interest is often desirable. We have used the Agilent SureSelectXT target enrichment system. We have designed and used several custom-designed targeted capture sets against both nuclear and mtDNA from a number of organisms, including humans, mice and flies, with good success. Hybridization-based enrichment methods offered by other manufacturers would probably work as well. However, we have not evaluated these technologies, and they are likely to require some optimization. Of note, PCR-based enrichment methods are not compatible with DS because the targeted duplex DNA is melted into its single-stranded components during PCR, and the complementarity of the original DNA is lost.
Capture is readily performed on large targets, or on high-copynumber targets such as mtDNA. However, capture is inefficient when targeting small, low-copy-number regions. The reason is that capture typically results in a 10,000-fold enrichment of the target DNA. For example, the mitochondrial genome, owing to its high copy number, composes ~0.2% of the total mass of DNA in a human cell. Therefore, a 10,000-fold enrichment will result in nearly 100% purity of the targeted DNA. However, a 20-kb locus in genomic DNA, which is present in a single copy per haploid genome, composes only 0.0007% of the total DNA. Thus, a 10,000-fold enrichment will result in only 7% of the final DNA being on-target. However, we have found that repeating the targeted capture steps typically results in >85% of reads mapping to the target sequence.
Quality metrics. The overall efficiency of DS is calculated by dividing the number of DCS reads by the number of raw reads, and in our hands it can range from 1 to 10%. We have found that two primary factors determine overall data yield: the peak family size and the SSCS:DCS ratio. The peak family size is determined by the amount of DNA used for the PCR and the fraction of a lane dedicated to a sample, and it should optimally be adjusted to six, as discussed previously (see the 'Setting tag family size by PCR amplification' section; Fig. 5a ). Should a sample exhibit a peak family size that is smaller than what is desired, then an optimal peak family size can be obtained by resequencing the same sample using the information in Supplementary Table 2 and combining the data with the previous run(s). Importantly, the resequenced sample must be a technical replicate; performing the protocol again on the same biological sample will not work. The SSCS:DCS ratio is the other key factor. A ratio of two is the theoretically ideal and would indicate that every SSCS can find its partner and form a DCS. We typically obtain SSCS:DCS ratios between four and ten, with an average of ~6. An excessively high ratio (i.e., >14-15) can occur for several reasons. If peak family sizes are too small, then families with at least three members might not form from both DNA strands. This issue is readily overcome by increasing the family size, as noted above, although it does not appreciably improve above peak sizes of 5-6 (Fig. 5b) . If a poor ratio is seen despite adequate family sizes, this suggests that only one of the two DNA strands was successfully ligated and amplified during PCR. In such cases, the sample library will need to be remade in order to obtain more data, with attention to optimizing ligation conditions and library tailing steps.
Finally, mutations should theoretically be distributed throughout all possible read positions; however, we observe an increased frequency of mutations at the 5′ and 3′ends of reads. These artifacts are likely due to errors that occur during the end-repair process and alignment. These artifacts can be mitigated by performing local re-alignment with GATK, followed by clipping the first and last five bases of each read 39 . Table 3 for sequences)  crItIcal Oligonucleotides must be PAGE purified. Sequencing adapter PCR oligonucleotide primers (IDT; see Table 3 for sequences NEBNext end-repair module (NEB, cat. no. E6050L; includes reaction buffer) NEBNext dA-tailing module (NEB, cat. no. E6053L; includes reaction buffer) Ultrapure T4 ligase (600,000 U/ml; Enzymatics, cat. no. L6030-HC-L; supplied with 10× Ultrapure ligation buffer) KAPA HiFi HotStart DNA polymerase (1 U/ml; KAPA Biosystems, cat. no. KK2502; supplied with 5× fidelity buffer and 10 mM dNTP mix) SYBR Green (10,000×; Life Technologies, cat. no. S-7563) Agilent DNA high-sensitivity D1K TapeStation kit (Agilent, cat. no. 5067-5363 and 5067-5364). Alternatively, an Agilent high-sensitivity DNA for the Bioanalyzer 2100 may be used (Agilent, cat. no. 5067-4626) Agilent SureSelectXT target enrichment Set (protocol version 1.6; Agilent)  crItIcal The use of target enrichment is optional for this protocol. The target enrichment section uses Agilent SureSelectXT. The use of other targeted capture products will probably work; however, they have not been evaluated and their compatibility is unknown. SureSelectXT reagent kit, HSQ, 16 (Agilent, cat. no. G9611A) This item is optional and is needed only if targeted capture is performed • 
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2|
Transfer the DNA to a Covaris sonication tube and shear DNA using the settings outlined in Equipment Setup.  crItIcal step Ensure that there are no air bubbles in the bottom of the tube after loading the sample. In the case of air bubbles, gently tap or shake to bring the solution to the bottom of the well. In addition, the water bath temperature should be 4 °C, and the water bath should be degassed for 30 min before shearing.
3|
Vortex the room-temperature AMPure XP bead mixture to resuspend any magnetic particles that may have settled.  crItIcal step The beads must be at room temperature before use. A cold bead mixture significantly reduces yield.
4|
Split the 130 µl of sonicated DNA into 2 × 65-µl aliquots in 0.2-ml PCR tubes.
5|
Add 130 µl of AMPure XP beads to each PCR tube (2:1 bead:sample ratio) and mix well by vortexing or by pipetting up and down. The 2:1 ratio is used to ensure the maximal retention of all DNA.
6|
Incubate the mixture for 5 min at room temperature.
7|
Place PCR tubes onto the DynaMag-96 side magnetic plate separator (or equivalent) for at least 2 min or until all the beads are out of solution. Visually confirm that the beads have moved to the side of the tubes and that the solution is clear.
8|
Aspirate the supernatant from each tube and discard it. Keep the tubes on the magnetic plate separator.
9|
Carefully dispense 200 µl of room-temperature 75% (vol/vol) ethanol to each PCR tube and incubate the tubes for 30 s at room temperature.
10|
Aspirate out the ethanol and discard it. Repeat Steps 9 and 10 once more for a total of two washes.
11|
Allow the beads to dry for 5 min at room temperature until there are no visible traces of ethanol.  crItIcal step Overdrying or underdrying the beads reduces yield.
12|
Remove the PCR tubes from the magnetic plate separator and add 40 µl of ddH 2 O to only one of the two tubes of each sample and resuspend.
13| Carefully transfer the resuspended bead mixture to the second sample PCR tube and resuspend the beads. Let the bead mixture sit for at least 2 min. 17| Place the tube containing the end-repaired DNA onto the magnetic plate separator for at least 2 min or until all the beads are out of solution, and then transfer the supernatant (should be 85 µl) to a new 0.2-ml PCR tube. Discard the beads.
14|
18|
Add 55 µl of AMPure XP beads to the sample and incubate the tube at room temperature for 5 min. Place the PCR tube onto the magnetic plate separator for at least 2 min or until all the beads are out of solution, and discard the 140-µl supernatant. Keep the beads.
19|
Repeat the double 75% (vol/vol) ethanol wash outlined in Steps 9-11.
20|
Remove the PCR tube from the magnet and add 42 µl of ddH 2 O to each sample and gently pipette up and down until the beads are resuspended. Let the bead mixture sit for at least 2 min.
21|
Place the PCR tube back onto the magnetic plate separator for at least 2 min or until all the beads are out of solution, and then transfer the supernatant to a new 0.2-ml PCR tube.  pause poInt Samples can be stored at −20 °C for up to several weeks.
3′ a-tailing of blunt-ended Dna library
• tIMInG 1 h 22| Combine the components in the table below in a 0.2-ml PCR tube and mix them carefully by pipetting up and down. Incubate the mixture in a thermocycler for 30 min at 37 °C. 23| Add 60 µl of AMPure XP beads (1.2:1 bead:sample ratio) and mix. The bead ratio selects against DNA fragments <150 bp in size. Incubate the tube for 5 min at room temperature.
24|
Place A-tailed DNA sample onto the magnetic plate separator for at least 2 min or until all the beads are out of solution, and then remove and discard the supernatant. 25| Repeat the double 75% (vol/vol) ethanol wash outlined in Steps 9-11.
26|
Remove the tube from the magnetic plate separator and resuspend the beads in 37 µl of ddH 2 O. Let the bead mixture sit for at least 2 min.
27|
Place the sample back onto the magnetic plate separator for at least 2 min or until all the beads are out of solution, and then transfer the 37 µl of eluent to a new 0.2-ml PCR tube.  pause poInt Samples can be stored at −20 °C for several weeks.
28| Remove 2 µl from the A-tailed library and quantify the amount of DNA using the high-sensitivity kits for either the Agilent TapeStation 2200 or Agilent Bioanalyzer 2100, according to the manufacturer's instructions. ? troublesHootInG ligation of Ds adapters to sample Dna • tIMInG 1 h 29| By using the amount of sample DNA determined in Step 28, calculate the amount of DS adapters (synthesized as described in boxes 1 and 2) that will be needed for a 20:1 molar excess relative to the total DNA concentration in the final ligation reaction. If necessary, dilute the adapters in ddH 2 O to an easily pipetteable volume.
30|
Mix the following components, in order, in a 0.2-ml PCR tube, and mix them carefully by pipetting up and down.
As noted in Step 29, the volumes of adapters and water that are used will need to be adjusted on the basis of the DNA concentration of your sample, but the total volume should be 60 µl. 31| Incubate the tube for 15 min at 25 °C in a thermocycler (no heated lid).
32|
Add 60 µl of AMPure beads (1.2× bead:sample ratio) and mix. This ratio selects against DNA fragments <150 bp in size. Incubate the tube for 5 min at room temperature.
33|
Place the PCR tube containing the ligated sample onto the magnetic plate separator for at least 2 min or until all the beads are out of solution. Remove and discard the supernatant.
34|
Repeat the double 75% (vol/vol) ethanol washes outlined in Steps 9-11, with the exception that the beads be fully resuspended in the ethanol by vortexing before being placed on the magnetic separator. Dry the beads for 5 min at 37 °C in a heat block with the tube cap opened.  crItIcal step Resuspending the magnetic beads during the ethanol washes is essential for removing adapter dimers that form during ligation. Failure to do so will adversely affect the downstream PCR steps. Removal of any residual ethanol by drying at 37 °C is also important, as ethanol inhibits PCR.  crItIcal step The number of PCR cycles is a crucial variable; a difference of a single cycle can result in nonspecific, higher-molecular-weight products appearing (Fig. 6b) . See 'PCR Amplification' in the INTRODUCTION for details on determining the number of PCR cycles.  crItIcal step The number of PCR cycles is a crucial variable; a difference of a single cycle can result in nonspecific, higher-molecular-weight products appearing (Fig. 6b) . See 'PCR Amplification' in the INTRODUCTION for details on determining the number of PCR cycles.
35|
39|
Transfer and pool all the PCRs from a single sample into a single 1.7-ml microcentrifuge tube.
40| Add 1.0 volumes of AMPure XP beads to the pooled PCRs (typically 50 µl of beads for every 50 µl of PCR). The bead ratio selects against DNA fragments <200 bp in size. Incubate the mixture for 5 min at room temperature.
41| Place the PCR sample onto a magnetic separator for at least 2 min or until all the beads are out of solution, and then remove and discard the supernatant.
42|
Remove the beads from the magnetic plate and resuspend them in 200 µl of room-temperature 75% (vol/vol) ethanol by vortexing.  crItIcal step Failure to completely resuspend the beads during this step can lead to the retention of nonspecific PCR products (supplementary Fig. 6 ).
43|
Place the microcentrifuge tube onto a magnetic separator for at least 2 min or until all the beads are out of solution, and then remove and discard the supernatant.
44|
Repeat Steps 42 and 43. Let the beads dry for 5 min.
45|
Remove the microcentrifuge tube from the magnetic plate separator and resuspend the beads in 20 µl of ddH 2 O. Let the bead mixture sit for at least 2 min.
46|
Place the sample onto the magnetic separator for at least 2 min or until all the beads are out of solution, and then transfer the 20 µl of eluent to a new 0. 
55|
The reference genome must be indexed before being used with BWA. Follow the instructions on the website (http://bio-bwa.sourceforge.net/bwa.shtml) using the recommended options relevant to the genome of interest.  crItIcal step The bioinformatics steps outlined in this protocol are specific to BWA. We have not used other sequencing aligners, and their compatibility with the downstream bioinformatics steps is not known.
bioinformatic processing: parsing and filtering duplex tags • tIMInG variable 56| Concatenate the 12-nt tag sequences from the paired reads and evaluate for tag quality using 'tag_to_header.py' using the following command: Adapters are not properly synthesized (bands in lane 4 of Fig. 3a do not match)
Adapters are not fully extended (Fig. 3a, lane 2 does not match) Replace reagents, re-anneal oligonucleotides and perform the extension reaction again Adapters are incompletely cut (Fig. 2a, lane 3 Depth is directly proportional to the number of DCS reads, which is directly proportional to the number of DNA molecules used as input in the PCR. If the number of molecules was too low, the depth will be too low. Further resequencing will only increase the family size, not the depth. Divide your peak family size by six, which is the optimal peak family size. Then increase the DNA amount in the PCR proportionally. For example, if the obtained peak family size is 24, 24/6 = 4, 4× more DNA is needed in the PCR 
antIcIpateD results
We have applied DS to a number of biological systems, including the M13mp2 phagemid 19 , human mtDNA from frozen brain tissue 33 and human nuclear DNA from both frozen and formalin-fixed samples (M.J.P., E.J.F. and L.A.L.; unpublished results). We consistently observe a >50,000-fold reduction in the apparent mutation frequency in these samples, relative to conventional NGS methods. We have found that SSCS formation is capable of removing almost all sequencer-derived false positives, which account for >99% of all artifacts. However, this step is unable to remove artifacts arising from first-round PCR errors that have been propagated to all tag family members. The mutational spectrum of the SSCS typically shows a high frequency of G→T mutations, which is the result of fixation of oxidative damage occurring during the DNA purification and processing steps 19 . Formation of the DCS reads consistently removes these artifacts, as well as those from other damage events, and it results in a further 90-99 + % reduction in mutational artifacts.
